Vaccine Panel Urges More Protection Against RSV, Meningitis and Chikungunya

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on April 17, 2025.

By I. Edwards HealthDay Reporter

THURSDAY, April 17, 2025 — A panel of federal health experts on Wednesday recommended expanded vaccine options for several diseases, including respiratory syncytial virus (RSV), meningitis and a mosquito-borne illness called chikungunya.

The panel, known as the Advisory Committee on Immunization Practices (ACIP), makes vaccine use recommendations to the director of the U.S. Centers for Disease Control and Prevention (CDC), The Associated Press reported.

These recommendations are almost always approved. But recent leadership changes at the CDC may complicate next steps.

Acting Director Susan Monarez, who is President Donald Trump's pick to lead the CDC, awaits U.S. Senate confirmation. Until that happens, she has recused herself from regular duties due to federal law regarding vaccines.

According to two CDC officials who spoke anonymously, decisions may now fall to U.S. Health Secretary Robert F. Kennedy Jr., a longtime anti-vaccine activist.

The new recommendations include:

  • Adults aged 50 to 59 with certain health problems, like heart disease, diabetes or chronic obstructive pulmonary disorder should be able to get the RSV shot.

  • A new combination vaccine from GSK was endorsed. It protects against five types of meningococcal bacteria, including one linked to college campus outbreaks about 10 years ago.

  • A second vaccine for chikungunya was recommended for travelers age 12 and older heading to countries with current outbreaks. About 100 to 200 cases of chikungunya are reported each year among U.S. travelers.

  • A safety warning was added to an older chikungunya vaccine that uses a weakened live virus. People 65 and older should discuss the risks with their doctor, especially if they have other health conditions. This follows reports of six older adults developing heart or brain symptoms shortly after getting the shot. The cases are stil being investigated.

    • Sources

  • The Associated Press, April 16, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-04-18 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords